Brief: TuHURA Biosciences Signs ATM Deal With H.C. Wainwright To Sell Stock Worth Up To $50 Million – SEC Filing
04/11/2025 12:42
Nov 4 (Reuters) - TuHURA Biosciences Inc HURA.O: TUHURA BIOSCIENCES INC: ENTERED INTO ATM AGREEMENT WITH H.C. WAINWRIGHT TO SELL SHARES OF COMMON STOCK FOR PRICE OF UP TO $50 MILLION - SEC FILING Source text: [ID:n0001193125-25-263523] Further company coverage: HURA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.